Comparison of adverse events associated with different spacers used with non-extrafine beclometasone dipropionate for asthma

Co-prescription of Aerochamber(®) spacer with non-extrafine beclometasone diproprionate (non-EF BDP) is common but unlicensed. We report a comparison of inhaled corticosteroid (ICS)-related adverse events between patients co-prescribed Aerochamber compared to the licensed Volumatic(®) spacer. We uti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ming, Simon Wan Yau, Haughney, John, Ryan, Dermot, Patel, Shishir, Ochel, Matthias, d’Alcontres, Martina Stagno, Thornhill, Susannah, Kocks, Janwillem W. H., Price, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368625/
https://www.ncbi.nlm.nih.gov/pubmed/30737400
http://dx.doi.org/10.1038/s41533-019-0115-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368625/
https://www.ncbi.nlm.nih.gov/pubmed/30737400
http://dx.doi.org/10.1038/s41533-019-0115-0

Ejemplares similares